Basit Jabbar is a postdoctoral researcher in Professor Niklas Arnberg’s group, studying antiviral compounds targeting virus–host interactions, with a focus on human parainfluenza viruses.
Infectious diseases remain a major global health challenge, contributing substantially to global morbidity and mortality. Among these, respiratory infections—including influenza viruses, respiratory syncytial virus (RSV), adenoviruses, coronaviruses, and human parainfluenza viruses—are leading causes of illness worldwide. Annual influenza epidemics worldwide are estimated to cause approximately 3–5 million cases of severe illness and 290,000–650,000 respiratory deaths each year (World Health Organization: WHO, 2023). In addition, infectious diseases collectively account for a substantial global burden, contributing to hundreds of millions of disability-adjusted life years (DALYs) lost annually.
This persistent and evolving burden highlights the critical need for effective antiviral strategies and a deeper understanding of viral pathogenesis. Studying virus–host interactions is essential for identifying key molecular mechanisms that can be targeted to develop novel therapeutics. Targeting critical steps of the viral life cycle, particularly virus–host interactions, offers promising avenues for therapeutic development. Advances in antiviral research are therefore essential not only to reduce disease severity and transmission but also to strengthen global preparedness against future viral outbreaks and pandemics.
Basit Jabbar is a Postdoctoral Researcher in Niklas Arnberg Lab at the Department of Clinical Microbiology, Umeå University, Sweden working since September 2025. His research interests are virus–host interactions and identification and evaluation of antiviral compounds, with particular emphasis on clinically significant viral pathogens, particularly parainfluenza viruses. By targeting and disrupting virus–host interactions, his work aims to advance innovative therapeutic strategies to combat emerging and re-emerging infectious diseases and strengthen global pandemic preparedness. His work is driven by a forward-looking vision to bridge fundamental research and real-world health challenges, contributing to global efforts in infectious disease control and pandemic preparedness.
He has made significant scholarly contributions to the field of molecular biology, virology and infectious diseases, with 20 peer-reviewed publications in international journals. His work has collectively achieved a cumulative impact factor of around 55, with a strong and growing citation record reflected in an h-index of 12 and more than 500 citations. A substantial proportion of his publications appear in high-impact, Tier 1 journals, demonstrating the quality, rigor, and relevance of his research.
He earned his PhD degree in Molecular Biology from the Centre of Excellence in Molecular Biology, University of the Punjab, Pakistan in the year 2023. His expertise encompasses molecular biology, virology, bioinformatics, and translational research- with a focus on translating fundamental scientific discoveries into practical applications for disease diagnosis, therapeutic development, and prevention strategies. Prior to his current role, he contributed extensively to public health initiatives as a Program Officer in the Hepatitis and Infection Control Program in Government of the Punjab Primary & Secondary Healthcare Department (Health and Population Department)/ Directorate General Health Services Punjab, Pakistan, where he worked on large-scale diagnostics for Hepatitis B and C viruses, infection control strategies, and healthcare program implementation.
His achievements have been recognized through multiple academic and professional distinctions, including first position in his M.S. Biotechnology program and merit-based scholarships during his postgraduate studies, as well as several international and governmental recognitions. These include a Shield and Certificate of Appreciation for Outstanding Achievement in Healthcare Service Delivery awarded by the Director General Health Services, Government of Punjab, Pakistan and a Certificate of Appreciation during World Antimicrobial Awareness Week jointly recognized by the Healthcare Department Punjab, Pakistan and the WHO. He also received a Certificate of Recognition for his contributions to the Hepatitis Micro-Elimination Project and for his efforts in the Hospital Waste Management Project, reflecting his impactful role in large-scale healthcare programs and disease control efforts.